Netherlands· NL-719b98c64cb8
Zilbrysq 23 mg oplossing voor injectie in een voorgevulde pen
A zilucoplan product containing zilucoplan tetranatrium, registered in Netherlands by UCB Pharma S.A.. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Zilucoplan is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AJ06 (zilucoplan), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Zilucoplan · ATC L04AJ06
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ZILUCOPLAN TETRANATRIUM
- Manufacturer
- UCB Pharma S.A.
- Country
- Netherlands (NL)
- ATC code
- L04AJ06
- ATC class
- Zilucoplan
- Defined daily dose
- 23 mg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/23/1764
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zilucoplan in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceZILBRYSQ 23 mg, solution injectable en seringue préremplieUCB PHARMA BELGIQUE
- IrelandZilbrysq 23 mg solution for injection in pre-filled syringeUCB Pharma S.A.
- CzechiaZILBRYSQUCB Pharma SA, Brusel
- FinlandZilbrysqUCB Pharma SA
- SpainZILBRYSQ 16,6 MG SOLUCION INYECTABLE EN PLUMA PRECARGADAUcb Pharma
- SwedenZILBRYSQ 16,6 mg Injektionsvätska, lösning i förfylld injektionspennaUCB Pharma S.A.
- BelgiumZilbrysq 16.6 mgUCB Pharma
- IcelandZilbrysqUCB Pharma S.A.*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zilbrysq
- Liechtenstein · Zilbrysq
- Norway · Zilbrysq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/91a2ffd8-aa81-45a8-80d0-04586c3670f3 GET /v1/drugs/91a2ffd8-aa81-45a8-80d0-04586c3670f3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Subcutaan gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/zilbrysq-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Zilucoplan",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp136938",
"excipients": [
"DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
"NATRIUMCHLORIDE",
"NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
"WATER VOOR INJECTIE"
],
"substances": [
"ZILUCOPLAN TETRANATRIUM"
],
"leaflet_url": null,
"authorised_at": "2023/12/01",
"procedure_number": "EMEA/H/C/005450",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/23/1764",
"additional_monitoring": "Y"
}See everything about zilucoplan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.